Thesis (Ph.D.) - University of Queensland, 2005. / Includes bibliography.

Thesis (M.S.)--Oregon State University, 2007. / Printout. Includes bibliographical references (leaves 56-62). Also available on the World Wide Web.

Thesis (Ph. D.)--Auburn University. / Abstract. Includes bibliographical references.

The purpose of this project was to fabricate biodegradable ophthalmic inserts for controlled delivery of pilocarpine and evaluate them by both in-vitro and in-vivo studies. Emphasis was placed on the use of an inexpensive material as a drug carrier and on the ease of fabrication of the device. Based on these criteria, absorbable gelatin was selected to fabricate a matrix system. Absorbable gelatin can be obtained by either thermal treatment or chemical crosslinking of gelatin. In the first part of this project, we fabricated an insert using Gelfoamᴿ, an absorbable gelatin sponge obtained by thermal treatment. A prolonged in-vitro release of pilocarpine from the device was achieved through pharmaceutical modification by embedding a retardant in the pores. The devices impregnated with polyethylene glycol monostearate (PMS) and cetyl esters wax (CEW) were found to be most effective. The in-vivo evaluation of the devices indicated that pharmaceutical modification of Gelfoamᴿ is an effective means of improving the biological activity of pilocarpine without altering the biodegradability of the biopolymer backbone. The CEW device produces a substantial improvement in drug bioavailability and an increase in the duration of biological effect over that from the two commercial formulations, the eyedrop and the gel. In the second part of the project, we fabricated absorbable gelatin inserts through chemical crosslinking of gelatin. The effect of selected fabrication variables on profiles of the in-vitro release of pilocarpine and the dynamic water uptake by the crosslinked gelatin devices was investigated. These results were further substantiated by the measurement of the degree of crosslinking of gelatin. The in-vivo study indicated that the modification of the structure of gelatin by crosslinking is another simple and effective way of improving bioavailability and extending the duration of effect of pilocarpine incorporated in the biopolymeric device. In addition, altering the degree of crosslinking of gelatin allows a variation of the biodegradation time of the polymer.

A variety of “clickable” self-assembling peptide-amphiphile hydrogel systems are reported. Covalently linked hydrogels were prepared using alkyne-azide “click” chemistry and thiolene photochemistry, which were used in combination with short self-assembling peptideamphiphile compounds. For alkyne-azide “click” hydrogels, samples were formed from a mixture of two peptideamphiphiles which were separately disubstituted with alkyne or azide functionalised amino acids. This allowed for production of an extensively triazole-linked hydrogel product when gelation was performed in combination with the appropriate “click” pre-catalyst and reductant. For thiol-ene photochemical hydrogels samples were formed from a mixture of two peptideamphiphiles which were separately disubstituted with cysteine or Alloc-protected lysine. UV exposure was used to catalyse the covalent linking of the asembled hydrogel. Michael addition thiol-ene reactions were also investigated as a potential covalent linking method. A number of model reactions were attempted on specially synthesised amino acids. Results were promising, but a number of difficulties were encountered which made them unsuitable for incorporation in a hydrogel system. The hydrogel samples produced were all found to be viscoelastic hydrogels through analysis by rheological methods. A variation in the stiffness of the samples was observed, with samples having Young’s modulus values in the soft to intermediate range when compared to that of various tissues. SEM analysis indicated the hydrogels exhibited a fibrous nanostructure. The biological activity of the hydrogel samples was investigated by 2D seeding of cells on hydrogel samples. A LIVE/DEAD assay was performed which indicated hydrogel samples were able to support cell attachment and growth in vitro.

[Truncated abstract] The synthetic hydrogel poly(2-hydroxyethyl methacrylate) (PHEMA) has been used as a biocompatible biomaterial in ocular devices, such as soft contact lenses, intraocular lenses and an artificial cornea. Due to its favourable properties as an already established (but non-biodegradable) biomaterial, PHEMA is an interesting candidate for use as a material for scaffolds in tissue engineering. A tenant of tissue engineering scaffolds is obtaining the appropriate porous morphology to allow for successful cellular attachment and support. PHEMA hydrogels exhibit varied morphological features, which range from non-porous (homogeneous) to macroporous (heterogeneous) and can be readily obtained by fine-tuning the polymerisation conditions. A desirable feature for matrices that are to be used as tissue supports is the ability to biodegrade in a biological environment. This thesis describes the preparation and enzymatic biodegradation behaviour of novel porous PHEMA hydrogels that have been crosslinked with biodegradable peptide-based crosslinking agents. Peptide-based crosslinking agents were designed to contain two terminal polymerisable groups flanking an internal biodegradable backbone. This backbone was specifically designed to be targeted by the proteolytic enzyme papain. The general design template allowed for the development of a synthetic methodology that was readily implemented for the production of a range of olefin-peptide conjugates. A suite of olefin-peptide conjugates of general structure I were synthesised, characterised and further tested with papain to determine their biodegradation properties. ... The second strategy for producing bioresorbable degradation fragments involved the incorporation of the highly hydrophilic comonomer, poly(ethylene glycol) PEG into the PHEMA backbone. The addition of PEG to PHEMA resulted in the formation of homogeneous hydrogels that had an improved hydrophilicity compared to their heterogeneous PHEMA counterparts. The synthetic conditions for the preparation of PHEMA and PHEMA-co-PEG hydrogels by photoinitiated polymerisation were thoroughly investigated. It was found that the pore morphology and general properties (non-porous to macroporous) of these hydrogels could be controlled by the appropriate choice of polymerisation conditions. The hydrogels were characterised by scanning electron microscopy, thermal gravimetric analysis and differential scanning calorimetry. The peptide-based crosslinking agents were successfully co-polymerised with the HEMA and PEGMA via photoinitiated polymerisation to provide a range of PHEMA and PHEMA-co-PEG hydrogels that displayed both homogeneous and heterogeneous hydrogel properties. The final crosslinked hydrogels were characterised by scanning electron microscopy and were subjected to enzymatic hydrolysis. The PHEMA-peptide conjugate hydrogels proved to be biodegradable, with degradation behaviour dependent on the hydrogel formulation and the length of the peptide-based crosslinking agent.

Thesis (M.Sc. (Pharmacy)) - Rhodes University, 2008

Erythromycin (ERY) is a macrolide antibiotic which is used in the treatment of acne vulgaris.Acne is a common skin condition that occurs when the sebaceous glands and hair shafts become infected by the bacteria Propionibacterium acnes. Acne is a chronic condition that may last for years and the severity of the effects of the disease on patients is often undermined especially in third world countries where more emphasis is placed on other more life-threatening diseases. It may cause considerable physical and emotional distress to sufferers along with the possibility of permanent scarring. Although use of topical ERY formulations is not the first line of treatment it has proven to be effective in treating inflammation of skin and skin structures cause by the responsible bacteria. To-date there are a variety of vehicles which are used in preparing topical ERY formulations namely ointment and gel bases, alcoholic solutions and pledgets. All the gel formulations on the market contain hydroxypropyl cellulose, alcohol and water along with the active ingredient(s). However, some gel formulations contain propylene glycol in addition to these excipients an example being Emgel®. Propylene glycol has been shown to affect the penetration of topically applied drugs through the skin suggesting that it would be highly likely that those formulations which contain propylene glycol may release more ERY into the skin following application. With this in mind, two ERY gel formulations were produced which contained different percentages of propylene glycol. According to the FDA guidelines, pharmacokinetic measurements in blood, plasma and/or urine of topical dermatological drug products are not feasible to document bioequivalence since the active ingredient(s) in topical formulations is/are not intended to be absorbed into the systemic circulation and in addition, concentrations in extracutaneous biological tissues would generally not be measurable. This limits determination of bioavailability and assessment of bioequivalence of such products to pharmacodynamic measurements, clinical trials and dermatopharmacokinetic (DPK) measurements such as tape stripping (TS) and microdialysis (MD).TS is a sampling technique which involves sequential removal of layers of the stratum corneum using strips of adhesive tape. This technique has found increasing use in DPK studies for investigation of drug kinetics in the skin following the application of a topical formulation. The technique has also been used as a diagnostic tool in assessing the quality of the stratum corneum in diseased skin. In the current research study, the tape stripping technique was used to investigate the pharmaceutical/biological availability of topical gel formulations containing ERY. MD is another DPK sampling technique which has been used to determine the amount of a topically applied drug that penetrates through the stratum corneum to reach deeper tissues of the skin. The in vivo sampling technique involves the insertion of microdialysis probes beneath the skin surface in the dermal tissue and allows for real-time sampling of the analyte at its target site. Recently in vitro MD has also been successfully used to assess the pharmaceutical availability of a topical corticosteroid, mometesone furoate, from topical formulations. Based on this work, microdialysis was used to determine the pharmaceutical availability of ERY from gel formulations which were developed for use in this research. The results of the pharmaceutical availability of ERY from in vivo tape stripping studies and the in vitro microdialysis studies were compared to establish correlation between the data. Pharmaceutical equivalence and bioequivalence data obtained from the respective studies on the gel formulations were investigated by statistical analysis of the data generated from both the in vitro and in vivo experiments. In summary the objectives of this research were: 1. To develop and validate a high performance liquid chromatography method suitable to analyse ERY concentrations obtained from in vitro microdialysis studies and in vivo tape stripping studies. 2. To prepare two different ERY gel formulations with different percentage content of propylene glycol. 3. To determine the pharmaceutical availability of ERY from two different gel formulations using in vitro microdialysis. 4. To develop and validate a tape stripping technique which could be used to determine percutaneous penetration and bioequivalence of the gel formulations. 5. To compare in vitro microdialysis and in vivo tape stripping data and attempt to establish a correlation between the two different approaches.